"Recombinant Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins prepared by recombinant DNA technology.
| Descriptor ID |
D011994
|
| MeSH Number(s) |
D12.776.828
|
| Concept/Terms |
Recombinant Proteins- Recombinant Proteins
- Proteins, Recombinant
- Proteins, Biosynthetic
- Biosynthetic Proteins
Proteins, Recombinant DNA- Proteins, Recombinant DNA
- DNA Proteins, Recombinant
- Recombinant DNA Proteins
- DNA Recombinant Proteins
- Proteins, DNA Recombinant
- Recombinant Proteins, DNA
|
Below are MeSH descriptors whose meaning is more general than "Recombinant Proteins".
Below are MeSH descriptors whose meaning is more specific than "Recombinant Proteins".
This graph shows the total number of publications written about "Recombinant Proteins" by people in this website by year, and whether "Recombinant Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 6 | 6 |
| 1995 | 0 | 5 | 5 |
| 1996 | 0 | 11 | 11 |
| 1997 | 1 | 10 | 11 |
| 1998 | 2 | 12 | 14 |
| 1999 | 0 | 16 | 16 |
| 2000 | 0 | 9 | 9 |
| 2001 | 0 | 9 | 9 |
| 2002 | 2 | 20 | 22 |
| 2003 | 1 | 16 | 17 |
| 2004 | 0 | 18 | 18 |
| 2005 | 1 | 15 | 16 |
| 2006 | 0 | 11 | 11 |
| 2007 | 0 | 11 | 11 |
| 2008 | 2 | 18 | 20 |
| 2009 | 0 | 10 | 10 |
| 2010 | 2 | 21 | 23 |
| 2011 | 2 | 9 | 11 |
| 2012 | 0 | 14 | 14 |
| 2013 | 0 | 13 | 13 |
| 2014 | 0 | 7 | 7 |
| 2015 | 1 | 12 | 13 |
| 2016 | 0 | 9 | 9 |
| 2017 | 0 | 6 | 6 |
| 2018 | 1 | 5 | 6 |
| 2019 | 0 | 7 | 7 |
| 2020 | 0 | 2 | 2 |
| 2021 | 0 | 5 | 5 |
| 2022 | 1 | 3 | 4 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Recombinant Proteins" by people in Profiles.
-
Recombinant ADAMTS13: an effective rescue therapy for acute cTTP during pregnancy. Blood Adv. 2024 Jul 23; 8(14):3718-3720.
-
N-dihydrogalactochitosan serves as an effective mucosal adjuvant for intranasal vaccine in combination with recombinant viral proteins against respiratory infection. Acta Biomater. 2024 Feb; 175:279-292.
-
Time- and cost-efficient bacterial expression and purification of potato apyrase. Protein Expr Purif. 2023 03; 203:106215.
-
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors. Haemophilia. 2022 Jul; 28(4):548-556.
-
Overproduction of Membrane-Associated, and Integrated, Proteins Using Saccharomyces cerevisiae. Methods Mol Biol. 2022; 2507:111-141.
-
Purification of Membrane Proteins Overexpressed in Saccharomyces cerevisiae. Methods Mol Biol. 2022; 2507:143-173.
-
Rapid screening of high expressing Escherichia coli colonies using a novel dicistronic-autoinducible system. Microb Cell Fact. 2021 Dec 11; 20(1):223.
-
A Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity. Int J Mol Sci. 2021 Nov 07; 22(21).
-
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors. Haemophilia. 2021 Nov; 27(6):921-931.
-
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors. Haemophilia. 2021 Nov; 27(6):911-920.